Book Value per Share: Dermata Therapeutics (DRMA)

Graphic logo of Dermata Therapeutics (DRMA)

The current BVPS value demonstrates the net asset dynamics of Dermata Therapeutics (DRMA), while 0.87 reflects the metric's latest value. Geopolitical instability complicates the procurement of biomaterials and the execution of global trials. The absence of proprietary manufacturing plants minimizes capital expenditures, ensuring flexible profit scaling. Future business growth relies on the success of innovative nanogels in the therapy of severe acne.

Dermata Therapeutics Inc (DRMA): Share Book Value from 07/04/2022 to 10/27/2026

dermatarx.com - analytical breakdowns and key metrics (DRMA)

- price and consensus price forecast:
Price Chart Dermata|DRMA - Consensus Target
- market capitalization data:
Market Capitalization Dermata Therapeutics, Inc.|DRMA - Enterprise Value
- book capitalization data:
Net Assets per Single Share Dermata Therapeutics|DRMA - Net Asset Value|Market Capitalization to Book Value Ratio dermatarx.com|DRMA - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Dermata Therapeutics|DRMA - Long-Term Debt to Capital|Short-Term Debt to Equity Dermata Therapeutics, Inc.|DRMA - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Dermata Therapeutics, Inc.
Fundamental company valuation:Dermata - DRMA
Manufactured products of Dermata Therapeutics, Inc.

This indicator determines the net equity per share, identifying the fundamental margin of safety and the gap between the market price and tangible assets. By analyzing the actual book value per share, an investor assesses overpayment risks, which is critical for Dermata Therapeutics (DRMA) when financing the costly implementation of zero-waste technologies and eco-friendly drug synthesis in laboratories.

Competitors of Dermata Therapeutics (DRMA)

KRYS: Net Assets per Single Share|APGE - Accounting Value per Share|ARQT: Book Value per Share|VCEL (vcel.com) - Book Value per Share|Net Assets per Single Share Oruka Therapeutics ORKA|Share Book Value Sanara|DBV Technologies S.A. (DBVT) - Book Value per Share|Accounting Value of a Share solesence.com (SLSN)|Book Value per Share DERM (Journey Medical Corporation)|fortebiorx.com - Book Value per Share|Net Assets per Single Share Empro Group (EMPG)|SLGL: Accounting Value of a Share|AXIL (reviveprocare.com) - Net Assets per Single Share|Medicus Pharma Corp (MDCX) - Accounting Value per Share|VRCA (Verrica Pharmaceuticals Inc) - Book Value per Share|Book Value per Share Hoth (HOTH)|Biofrontera Inc. (BFRI) - Accounting Value per Share|Accounting Value of a Share VYNE (vynetherapeutics.com)|Net Assets per Single Share SNOA|Quoin Pharmaceuticals Ltd - Net Assets per Share|Azitra, Inc. - Net Assets per Single Share|ELAB - Book Value per Share|Revance Therapeutics, Inc. - Book Value per Share